Novel high energy intermediate analogues with a triazasterol structure as potential ergosterol biosynthesis inhibitors IV: Antimicrobial activity of mono-, bi-, and tricyclic 8,13,15-triazasteroid analogues including the synthesis of novel 4-alkylamino- and 4-alkenylamino-9-hydroxypyrimidoisoquinolines

Archiv der Pharmazie

Volumn 336, Issue 6-7, 2003, Pages 336-344

  Gößnitzer, Edith ^a   Punkenhofer, Asbjörn ^a   Ryder, Neil S ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b Institutes for Biomedical Research   (United States)

Author keywords

2 Imidazolin 2 amines, N2 and N 2 4 substituted; 4 Alkylamino and 4 alkenylamino 9 hydroxy; Guanidines, N Alkyl N (phenethyl and cyclohexenylethyl); Tetrahydro 2H pyrimido 4,3 a isoquinolines

Indexed keywords

4 (6 ISOPROPYL 3 METHYL 6 HEPTENYLAMINO) 9 HYDROXYPYRIMIDOISOQUINOLINE; 4 AMINO 9 HYDROXY 1,6,7,11B TETRAHYDRO 2H PYRIMIDO[4,3 A]ISOQUINOLINE; 9 HYDROXYPYRIMIDOISOQUINOLINE; 9 METHOXYPYRIMIDOISOQUINOLINE; 9 METHOXYTHIONE; AMINOHYDROXYPYRIMIDOISOQUINOLINE; BICYCLIC 8,13,15 TRIAZASTEROID DERIVATIVE; ERGOSTEROL; MONOCYCLIC 8,13,15 TRIAZASTEROID DERIVATIVE; N' (CYCLOHEXENYLETHYL)GUANIDINE; N' (PHENETHYL)GUANIDINE; N4 AMINOPYRIMIDOISOQUINOLINE; TRIAZASTEROL DERIVATIVE; TRICYCLIC 8,13,15 TRIAZASTEROID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEROL SYNTHESIS;

EID: 0041321080     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300774     Document Type: Article

References (22)

1. W. Köller, Target Sites Fungic. Action 1992, 119-206.
2. A. Polak, P. G. Hartmann, Prog. Drug Res. 1991, 37, 181-269.
3. N. S. Ryder, Br. J. Dermatol. 1992, 126 (Suppl. 39), 2-7.
4. L. W. Parks, W. M. Casey, Annu. Rev. Microbiol. 1995, 49, 95-116.
5. Y. Koltin, Annu. Rep. Med. Chem. 1990, 25, 141-148.
6. E. I. Mercer, Biochem. Soc. Trans. 1991, 19, 788-793.
7. A. Polak, Ann. N. Y. Acad. Sci. 1988, 544, 221-228.
8. M. Taton, P. Benveniste, A. Rahier, Bioorg. Chem. Healthcare Technol. 1991, 207, 23-37,
9. A. Rahier, M. Taton, P. Bouvier-Nave, P. Schmitt, P. Benveniste, F. Schuber, A. S. Narula, L. Cattel, C. Anding, P. Place, Lipids 1986, 21, 52-62.
10. E. Gößnitzer, R. Malli, S. Schuster, B. Favre, N. S. Ryder, Arch. Pharm. Pharm. Med. Chem. 2002, 11, 535-546.
11. E. Gößnitzer, A. Punkenhofer, Monatsh. Chem. 2003, 134(6), 909-927.
12. E. Gößnitzer, A. Punkenhofer, A. Amon, B. Favre, Eur. J. Pharm. Sci. 2003, 19, 151-164.
13. I. T. Harrison, J. Chem. Soc. Chem. Commun. 1969, 616.
14. G. A. Olah, S. C. Narang, B. G. B. Gupta, R. Malhotra, J. Org. Chem. 1979, 8, 1247-1251.
15. H. J Reich, J. H. Rigby in Handbook for Reagents for Organic Synthesis, Acidic and Basic Reagents 1999, 44-47.
16. J. F. W. McOmie, M. L. Watts, D.E. West, Tetrahedron 1968, 24, 2289-2293.
17. 13C-NMR-Spektroskopie, Georg Thieme Verlag Stuttgart, 1984.
18. H. Günther in NMR Spectroscopy, Wiley, New York, 1998.
19. F. A. L. Anet Conformational Analysis of Cyclohexenes. In: The Conformational Analysis of Cyclohexenes, Cyclohexadienes, and Related Hydroaromatic Compounds (Ed.: P. W. Rabideau), VCH, Weinheim, Germany, 1989.
20. National Committee for Clinical Laboratory Standards, 1998. Reference method for broth antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. NCCLS document M38-P. NCCLS, Wayne, Pa, USA
21. National Committee for Clinical Laboratory Standards, 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS Document M27-A. NCCLS, Wayne, Pa, USA
22. National Committee for Clinical Laboratory Standards, 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - 5th edition. NCCLS document M7-A5, NCCLS, Wayne, Pa, USA